The Polish Polpharma is the largest pharmaceutical and drug manufacturing company. The company was founded in 1935 and privatized in 2000 only with the involvement of the Polish capital, which was launched and began large-scale investments into dynamic growth thereafter.
Today, the company has become an international medical / pharmaceutical player, which is present in Eastern and Central Europe, Central Asia and the Kaukázusokban. It employs approximately 7,500 Emer Poland and international markets.
The company Polpharma has subsidiaries in Lithuania, Ukraine, Belarus, Azerbaijan and Uzbekistan. Stretégiai continue cooperation in the field of patent transfer of Spanish Farmaprojects Nations. The Polpharma products are available in more than 50 countries. The product was added to 600 Polpharma group portfolio, and adding an additional 400 is in progress. The company’s products and prescription drugs used in the inpatient produces a wide range. Specializes in cardiology, digestive and neurological drugs manufacture, but also deals with the manufacturing of non-prescription products. The company is now displayed in the biopharmaceuticals market, like other partner companies, but also as its own biopharmaceuticals have drawn up their own scientific-research workshops and establishing a company.
The production takes place in accordance with the requirements of Good Manufacturing Practice (GMP) is the most modern plants. The company uses the latest technology to ensure that drugs are safe and to guarantee the safety of employees and the environment. The Polpharma continuously, safely and efficiently introduce new, appropriate expectations of pharmaceutical solutions to patients. In 2011, the company won first place as published by the Polish Academy of Sciences Institute of Economics, Poland’s most innovative companies ranking.
The Polpharma’s motto: People for People. The social sensitivity is an integral part of our strategy. The quality and safety of medicines for patients treated in the first place Polpharma. The company’s activity is characterized by a duty of care towards the natural environment. The Polpharma put in place a number of social and educational programs and the healthy lifestyle to the forefront. In 2001, the support of most pharmaceutical and medical research projects established in the Polpharma Scientific Foundation.
For more information about the company visit the Polpharmawww.polpharma.com here!